• Applied Protocols for PCI-32765 (Ibrutinib) in B-Cell and Gl

  2026-05-26

  PCI-32765 (Ibrutinib) enables high-precision BTK inhibition for dissecting B-cell receptor signaling and exploring novel vulnerabilities in ATRX-deficient glioma models. This guide delivers actionable protocols, troubleshooting intelligence, and direct cross-domain insights for translational research.

• CD163+ Macrophages Drive Granulosa Cell Apoptosis in PCOS Mo

  2026-05-25

  This study identifies elevated CD163 expression in ovarian macrophages as a key driver of granulosa cell apoptosis in polycystic ovary syndrome (PCOS). By linking immune cell activation to disrupted follicular development, the research clarifies inflammatory mechanisms underlying PCOS and highlights experimental strategies for further investigation.

• β-Amanitin in RNA Polymerase II Studies: Protocols & Innovat

  2026-05-25

  β-Amanitin is the gold-standard inhibitor for dissecting RNA polymerase II function, enabling precise mRNA synthesis inhibition assays and advancing transcriptional regulation research. Recent breakthroughs in computational hapten design and dual-toxin detection technologies further expand its impact from bench research to applied toxicology. This article delivers detailed workflows, troubleshooting strategies, and translational insights for maximizing the value of β-Amanitin in modern laboratories.

• Cytoskeleton-Dependent Autophagy Under Mechanical Stress

  2026-05-24

  This study demonstrates that mechanical stress-induced autophagy in human cells critically depends on cytoskeletal integrity, with microfilaments playing a primary role and microtubules an auxiliary one. These findings advance our understanding of mechanotransduction pathways and inform the design of cell proliferation inhibition and cancer chemoprevention assays.

• LNP-mRNA Delivery in Pregnancy: Structure, Route, and Immuno

  2026-05-23

  This study elucidates how the structure of lipid nanoparticles (LNPs) and their administration route critically influence mRNA delivery, immune responses, and maternal-fetal outcomes during pregnancy. The findings provide mechanistic guidance for designing potent, safe LNP-mRNA therapeutics for maternal health, highlighting the interplay between nanoparticle chemistry, immunogenicity, and pregnancy-specific physiology.

• EdU Imaging Kits (488): Precision Cell Proliferation Assays

  2026-05-22

  EdU Imaging Kits (488) redefine cell proliferation assays by enabling rapid, artifact-free S-phase DNA synthesis measurement via click chemistry. Optimized for fluorescence microscopy and flow cytometry, these kits streamline workflows and deliver high-content, reproducible data for advanced cancer and stem cell research.

• Human Gastrin I: Catalyzing Translational GI Research Innova

  2026-05-22

  This thought-leadership article synthesizes mechanistic insights and strategic guidance for translational researchers leveraging human Gastrin I peptide in gastrointestinal pathway research. It bridges recent advances in hiPSC-derived intestinal organoid models with evolving needs in drug discovery and clinical translation. Extending beyond standard product pages, it provides actionable protocols, competitive benchmarking, and a forward-looking outlook—anchored by evidence from recent literature and advanced product specifications.

• Position 3 Modification in GnRH Antagonists: Synthesis and A

  2026-05-21

  This study explores the impact of incorporating 3-(2-methoxy-5-pyridyl)-alanine at position 3 of degarelix, a potent GnRH antagonist, on its biological activity and receptor interaction. Findings reveal that the stereochemistry of this modification significantly affects in vitro potency and in vivo duration, providing valuable insights for peptide drug design targeting reproductive hormone regulation.

• Dual-Mode mRNA Reporters: Advancing Translational Research

  2026-05-21

  This thought-leadership article explores how dual-reporter mRNA tools such as EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP) are transforming the landscape of gene delivery, immune evasion, and imaging in translational research. The piece integrates mechanistic rationale, comparative validation, and protocol guidance, and sets a new vision for overcoming persistent barriers in mRNA-based therapeutics and vaccine discovery.

• Hexetidine (NSC-17764): Precision Antibacterial Workflows fo

  2026-05-20

  Hexetidine (NSC-17764) stands out as a robust antibacterial agent for oral infection research, excelling in both planktonic and biofilm inhibition assays. Streamline protocol design and troubleshooting with evidence-backed parameters and unique comparative insights from recent biofilm resistance studies.

• SZQ-3 Modulates NF-κB and Mitochondria to Prevent Osteoporos

  2026-05-20

  The referenced study introduces SZQ-3, a synthetic chromone–maleimide hybrid, as a dual-action modulator of bone cell fate through NF-κB pathway inhibition and mitochondrial stabilization. These findings highlight a promising, mechanistically targeted alternative for postmenopausal osteoporosis, with implications for safer and more effective therapies.

• Genistein and Cytoskeleton-Driven Autophagy: Novel Pathways

  2026-05-19

  Explore how Genistein, a 5,7-dihydroxy-3-(4-hydroxyphenyl)chromen-4-one, uniquely modulates cytoskeleton-dependent autophagy and cancer chemoprevention. This article reveals new mechanistic insights and practical assay strategies beyond current literature.

• Metabolic Intervention Amplifies Ferroptosis & Cuproptosis i

  2026-05-19

  This study introduces a nanosystem-based metabolic intervention strategy that synchronously enhances ferroptosis and cuproptosis in tumor cells by targeting glycolysis and NAD+ metabolism. The approach not only increases the susceptibility of cancer cells to regulated cell death but also remodels the tumor immune microenvironment, boosting anti-tumor immunity.

• JC-1 Mitochondrial Membrane Potential Assay Kit: Applied Ins

  2026-05-18

  The JC-1 Mitochondrial Membrane Potential Assay Kit from APExBIO redefines mitochondrial function analysis, delivering sensitive, ratiometric measurement of ΔΨm across apoptosis and immunomodulation workflows. Its integration of a robust dual-fluorescence readout and CCCP control enables researchers to dissect mitochondrial health with precision and troubleshoot complex cellular models with confidence.

• Personalized iPSC Platforms Advance Ultrare Rare Disease Tri

  2026-05-18

  This study introduces an iPSC-based clinical trial selection platform tailored to patients with ultrarare genetic variants, enabling preclinical drug efficacy and safety assessment. The approach demonstrates improved precision in therapeutic decision-making for Leigh-like syndrome and offers a model for highly personalized medicine in rare diseases.

478 records 12/32 page Previous Next First page 上5页 1112131415 下5页 Last page